Seems a little bizzare that the none of the 63m 6c options were exercised, yet the 6.2c placement was heavily oversubscribed. Anyhow I'm glad I got the opportunity to pickup the 1c options a few weeks ago. Looking good.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025